Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corporation (NYSE: DDD) generates a steady flow of news across healthcare, aerospace and defense, industrial manufacturing, software and capital markets. As a pioneer in additive manufacturing, the company regularly issues updates on new 3D printers, materials, software platforms and application-specific solutions, as well as regulatory milestones and strategic partnerships.
Recent announcements highlight growth initiatives in aerospace and defense, where 3D Systems reports strong momentum in production printing systems and custom metal parts, expansion of its Littleton, Colorado A&D Application Center of Excellence, and participation in U.S. Air Force–sponsored programs for next-generation metal printing technologies. The company also shares developments from its NAMI joint venture in Saudi Arabia, including agreements in energy, infrastructure inspection and collaborations with major defense contractors.
In healthcare, news items include FDA 510(k) clearance expanding indications for the VSP Orthopedics virtual surgical planning platform to skeletally mature adolescents, along with commentary on the role of personalized healthcare and patient-specific devices in the company’s Med Tech business. Product-focused releases cover new stereolithography solutions such as the SLA 825 Dual, investment casting tools like ArrayCast and Accura SbF, and jewelry-focused systems such as the MJP 300W Plus wax printer.
Investors will also find financial and corporate updates, including quarterly earnings releases, software strategy announcements involving 3D Sprint, Oqton MOS and 3DXpert, and transactions related to convertible notes and capital structure. This news page brings together these diverse updates so readers can follow how 3D Systems’ technologies, partnerships and financial decisions shape its role in additive manufacturing.
3D Systems (NYSE: DDD) will release its third quarter 2022 financial results after U.S. markets close on November 8, 2022. A conference call and webcast to discuss the results will be held on November 9, 2022, at 8:30 a.m. ET. The company has been a leader in additive manufacturing solutions for over 35 years, serving various industries including healthcare, aerospace, and automotive. Investors can access the webcast and replay through the company's investor relations website.
3D Systems (NYSE: DDD) announced that Amnovis, a Belgium-based additive manufacturing company, has integrated the DMP Flex 350 Dual into its production workflow. This dual-laser solution enhances productivity by at least 50% compared to single-laser systems while reducing costs. Amnovis aims to leverage this technology for high-quality medical devices and industrial applications. The DMP Flex 350 Dual offers flexible application use and efficient management of print jobs, contributing to a competitive edge in both medical and industrial sectors.
3D Systems (NYSE:DDD) will participate in William Blair’s virtual panel, “Advancing Healthcare Through 3D Bioprinting,” on September 23, 2022, at 12:00 p.m. ET. This event highlights advancements in healthcare via 3D printing technology. A recording will be accessible on their website post-event for seven days. With over 35 years of experience, 3D Systems leads in additive manufacturing, offering tailored solutions in diverse sectors like healthcare, aerospace, and automotive.
3D Systems (NYSE:DDD) has announced that Andrew Johnson, executive vice president and chief legal officer, will also serve as chief corporate development officer. This dual role includes overseeing mergers and acquisitions and forging new strategic partnerships. Johnson's extensive experience, including the completion of over 60 M&A transactions, positions him well for these expanded responsibilities. The company aims to capitalize on emerging opportunities in regenerative medicine through strategic partnerships, leveraging its recent acquisitions and technological advancements.
3D Systems announced two new production-grade materials: Figure 4 Tough Clear and DuraForm PAx Black. Figure 4 Tough Clear is the company's first clear material designed for long-term use, featuring enhanced clarity and mechanical properties for applications like lenses and consumer goods. DuraForm PAx Black offers injection-molding-like properties with low-temperature printing, high impact resistance, and significant long-term stability. Both materials aim to facilitate rapid production and integration into existing workflows, targeting various industrial applications. Availability is set for Q4 2022.
3D Systems (NYSE:DDD) has announced the launch of a new biotech company, Systemic Bio, aimed at revolutionizing drug development by leveraging advanced bioprinting technologies. The company will utilize its proprietary h-VIOS™ organ-on-a-chip platform to create vascularized human tissues for drug testing, potentially reducing costs and the reliance on animal testing. Initial seed funding of $15 million is provided, with expected revenues nearing $100 million annually within five years. Taci Pereira is appointed as CEO, bringing extensive experience in bioengineering.
3D Systems has partnered with HII to develop the copper-nickel alloy CuNi30, designed for direct metal printing. This innovation can potentially reduce lead times by up to 75%, addressing the needs in marine, offshore oil & gas, and chemical industries. The alloy boasts an average relative density of 99.88%, significantly surpassing traditional casting methods. CuNi30 will be available in Q4 2022, enhancing supply chain efficiency while minimizing inventory costs. This advancement could revolutionize manufacturing processes in sectors requiring corrosion-resistant materials.
3D Systems (NYSE:DDD) has appointed Dr. Toby Cosgrove and Dr. Bon Ku to its Medical Advisory Board, expanding its expertise in regenerative medicine. Dr. Cosgrove, former CEO of the Cleveland Clinic, brings extensive healthcare leadership and innovation experience. Dr. Ku, a leader in healthcare technology, directs the Health Design Lab at Thomas Jefferson University. Their appointments aim to enhance 3D Systems' growth in areas like human tissue printing and medical device innovation. Both professionals are expected to contribute significantly to the company’s strategic direction.
3D Systems Corporation (NYSE: DDD) reported Q2 2022 financial results, with revenue of $140.0 million, a 13.8% decline from Q2 2021. Non-GAAP revenue, excluding divestitures, increased 7.8% due to robust demand in Industrial and Healthcare sectors, despite supply chain issues. The company posted a diluted GAAP loss per share of $0.26. Cash reserves stand at $638.2 million. FY 2022 revenue guidance has been lowered to $530 million - $570 million, citing foreign exchange impacts and decreased customer spending.
3D Systems (NYSE:DDD) announced the appointment of Michael Turner as Executive Vice President and Chief Financial Officer, effective August 29, 2022. Turner, who brings over 20 years of financial expertise, previously served as CFO at Innovative Chemical Products and held various finance leadership roles at Albemarle Corporation. His experience includes driving financial controls and implementing technology-based strategies. CEO Dr. Jeffrey Graves expressed enthusiasm for Turner's impact on the company's growth trajectory. Wayne Pensky is recognized for his interim leadership during the transition.